Fulcrum Therapeutics, Inc. Analytics - Traffic, Statistics and Competitor Tracking


Fulcrum Therapeutics, Inc. Website Screenshot

http://www.fulcrumtx.com

Fulcrum Therapeutics, Inc. Company Intro

Modulating gene expression to treat the root cause of genetically defined diseases. Learn more about our pipeline and our culture.

Industry

Healthcare

Fulcrum Therapeutics, Inc. Headquaters

26 Landsdowne Street
Cambridge,02139
United States


Fulcrum Therapeutics, Inc. Share price

28 Oct 2020 01:40 GMT

$10.87

0.29 (2.74 %)


Fulcrum Therapeutics, Inc. Market cap

$287.705 M


WMC RANKING

2020

Fulcrum Therapeutics, Inc. # 202

Biotechnology



Latest Fulcrum Therapeutics, Inc. News

News 27 Oct 2020

Global Air Pollution Control Systems Market 2025 To Expect Maximum Benefit and Growth Potential During this COVID 19 Outbreak : Babcock & Wilcox Enterprises, Mutares, Elex, FLSmidth, Feida Group

The report critically assesses the frontline players and their company ... Inc, F. Hoffmann-La Roche Ltd, FibroGen Inc, Fulcrum Therapeutics Inc, Galapagos NV, ...

News 27 Oct 2020

Global Air Pollution Control Systems Market 2025 To Expect Maximum Benefit and Growth Potential During this COVID 19 Outbreak : Babcock & Wilcox Enterprises, Mutares, Elex, FLSmidth, Feida Group

The report critically assesses the frontline players and their company ... Inc, F. Hoffmann-La Roche Ltd, FibroGen Inc, Fulcrum Therapeutics Inc, Galapagos NV, ...

News 26 Oct 2020

Fulcrum Therapeutics Inc (NASDAQ:FULC) Kicks Off Its Phase ...

Fulcrum Therapeutics Inc (NASDAQ:FULC) announced earlier this month the launch of its Phase 1 trial to evaluate its pipeline sickle cell disease treatment ...

WMC Market Score


WMC Market to Revenue Score


Revenue Total Social Followers Total Social Posts Search Volume Digital Footprint Size Digital change (New Pages) WMC Market Score
Fulcrum Therapeutics, Inc. 0.05 1.25 4.08 0 0 0 3.99
Alexion Pharmaceuticals, Inc. 100 13.31 100 20 0 0 100
Vertex Pharmaceuticals Incorporated 97.58 100 4.32 26 0 0 97.51
3SBio Inc. 96.05 0 0 4 0 0 2.78
Incyte Corporation 40.27 14.26 7.19 100 0 0 90.89

Fulcrum Therapeutics, Inc. Market Financials


Revenue, Expenses, Profit


Company Revenue Expense Profit Market Cap WMC Sector Score
Fulcrum Therapeutics, Inc. $2,750 $70,966 $-67,598 $287.705M 202
Alexion Pharmaceuticals, Inc. $5,536,800 $2,523,000 $846,100 $26.301B 1
Vertex Pharmaceuticals Incorporated $5,402,685 $2,634,428 $2,080,775 $55.268B 2
3SBio Inc. ¥5,318,091 ¥3,085,221 ¥973,717 ¥19.039B 3
Incyte Corporation $2,229,409 $1,622,822 $446,906 $19.322B 4

Market Analytics


Company Search vs Top 4 Industry Competitors



Total Fulcrum Therapeutics, Inc. Social Followers vs Top 4 Industry Competitors



Fulcrum Therapeutics, Inc. Post vs Top 4 Industry Competitors


Book a demo

Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.

* required fields

You'll learn how to:

  • 1. Automatically monitor your entire digital landscape including competitors
  • 2. View all new industry activity in real time
  • 3. Monitor your position in your industry
  • 4. Enrich your reports and strategy
  • 5. Empower your teams with knowledge

Our platform is loved & trusted by avariety
of world-leading brands

  • unilever
  • wavesight
  • acca
  • abeerdeen
  • UK2
  • umbo
  • rb
Industries